|
Bextra InformationBextra is currently the fastest growing COX-2 inhibitor. It is intended to treat osteoarthritis and rheumatoid arthritis patients with the once-daily medication. Although an immediate hit, all COX-2 inhibitors, including Bextra, have found itself surrounded by controversy. Bextra has been proven to cause acute allergic reactions and skin diseases in some patients. In rare cases, taking Bextra causes fatal skin reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome. Pfizer said that because of these new findings, they will add a black box warning to the Bextra labeling, warning patients of these serious potential side effects. In a preliminary study, presented at the American Heart Association meeting on November 9, 2004, it was revealed that Bextra may cause an increased risk of heart attack and stroke in patients. Pfizer claims that these findings are unsupported. Plans are underway to study the effects of Bextra and other COX-2 inhibitors on cardiovascular health by Pfizer and the FDA. According to the largest COX-2 study to date, COX-2 inhibitors like Bextra may not be as safe as initially believed. The most concerning and potentially harmful effects of Bextra are the hints that an increased risk of heart attacks can occur with its use. While some experts are doubtful that the study will do little to help end the heart attack controversy, others acknowledge the importance of it. In order to properly determine if a cardiovascular risk exists when using Bextra and other COX-2 inhibitors, some experts believe researchers will need to perform further studies specifically on arthritis patients who already have coronary heart disease or at high risk of developing it. If you or someone you love has suffered one of the severe side effects from taking Bextra contact us today for help in finding experienced Bextra attorneys to help with your case.
|
Select a State. Make Contact. Make the Decision. |
